Wegovy alternatives: 4 options compared
Most common reasons: insurance denied Wegovy, intolerable nausea, plateau at maintenance dose, or seeking lower cost. Each alternative below addresses a different one of these drivers.
Last reviewed: June 2026 · Editorial pick at #1 · how we compare
Quick comparison table
| # | Alternative | Best for | Match type |
|---|---|---|---|
| 1 | Zepbound tirzepatide | Wanting greater average weight loss (SURMOUNT-1: ~22.5% at 15 mg vs Wegovy's ~14.9% in STEP-1) | Same FDA indication |
| 2 | Ozempic semaglutide | Type 2 diabetes patients where Ozempic is covered and Wegovy is not | Off-label but commonly prescribed |
| 3 | Saxenda liraglutide | Patients whose insurance only covers older-generation GLP-1, or who prefer daily dosing for finer control | Same FDA indication |
| 4 | Mounjaro tirzepatide | Type 2 diabetes patients seeking strong weight-loss side benefit | Related indication (insurance pathway differs) |
Each alternative, in depth
#1 — Zepbound
★ Editorial picktirzepatide
Best for
Wanting greater average weight loss (SURMOUNT-1: ~22.5% at 15 mg vs Wegovy's ~14.9% in STEP-1)
Key difference vs Wegovy
Different molecule (tirzepatide vs semaglutide). Dual GIP/GLP-1 receptor agonist may produce additional loss after semaglutide plateau. Requires re-titration from 2.5 mg.
#2 — Ozempic
semaglutide
Best for
Type 2 diabetes patients where Ozempic is covered and Wegovy is not
Key difference vs Wegovy
Same molecule (semaglutide) at lower max dose (2.0 mg vs Wegovy's 2.4 mg). FDA-approved for T2D, not chronic weight management. Off-label weight-loss prescribing increasingly scrutinized.
#3 — Saxenda
liraglutide
Best for
Patients whose insurance only covers older-generation GLP-1, or who prefer daily dosing for finer control
Key difference vs Wegovy
Liraglutide, daily injection. ~8% mean weight loss (SCALE Obesity) — lower than Wegovy but FDA-approved for chronic weight management. Generic liraglutide expected late 2026.
#4 — Mounjaro
tirzepatide
Best for
Type 2 diabetes patients seeking strong weight-loss side benefit
Key difference vs Wegovy
Same molecule as Zepbound (tirzepatide) but FDA-labeled for T2D. Covered under T2D criteria when obesity coverage is excluded.
Frequently asked about Wegovy alternatives
Quick answers
›What's the closest alternative to Wegovy?
Pharmacologically, Ozempic — same active ingredient (semaglutide). For weight loss specifically, Zepbound is the closest in indication (chronic weight management) with superior average outcomes in head-to-head trial data.
›Are there non-injection alternatives to Wegovy?
Yes. Rybelsus is oral semaglutide (currently approved only for T2D, not weight loss). Orforglipron is an investigational oral GLP-1 from Lilly with Phase 3 data; FDA decision expected 2026. Phentermine and bupropion-naltrexone are older oral options with much smaller effect sizes.
›Is there a generic alternative to Wegovy?
No generic semaglutide is FDA-approved as of 2026. Wegovy patent extends into the 2030s. Compounded semaglutide is no longer broadly available after FDA enforcement discretion ended.
Why trust this comparison
Independent
No equity in any telehealth service. We earn affiliate commissions on click-through and never alter rankings for revenue.
Affiliate disclosure →Primary sources
Every clinical claim is cited to FDA labels, peer-reviewed trials with DOI links, or specialty-society guidelines. Never secondary sources.
Editorial methodology →Editorial-revenue separation
Commission rates do not affect ranking, scoring, or inclusion. We publish negative findings on paying affiliate partners.
Editorial policy →